The Pandemic Encourages Innovative Thinking and New Partnerships in the Healthcare Industry

John Elliott, VP, Sales at Carevive spoke with Host Daniel J. Litwin on his observations about the industry at the HLTH 2021 Tradeshow in Boston, Mass.

Elliott noted many positive trends during the show and will benefit all in the industry, but most importantly the patients.

The biggest takeaways from the show in Elliott’s opinion are:

  • The investor community in attendance hoping to provide innovation resources
  • An eagerness for a collaborative approach
  • Acting on data-centric information
  • “The time is now” essence

Overall, attendees and exhibitors came equipped with a problem-solving mindset. Elliott believes the industry is on the precipice of something big with major tech vendors in attendance and companies thinking innovatively to solve problems.

“You’re pulling in skillsets or talent that traditionally hasn’t been invested in or focused on healthcare; I think there has been a shift. A health system having an innovation team or even an own strategic investment team on where they can work with third party partners, and they’re allocating their own investment or capital funds to fill gaps.”

To put it short, it’s disruptive to the industry in the best way and is one example of how the pandemic is having a positive impact on the healthcare industry.

However, the pandemic has posed significant problems for many in healthcare, and oncology is no exception. Traditional chemo infusion was impacted by COVID-19, making it unsafe for the immune-compromised to receive treatment. Luckily, they were able to transition to an oral regimen for a safer patient experience. However, what was the downstream impact on those patients? Luckily, Carevive had the technology to help care teams better support their patients.

Carevive serves as a cancer management platform for improving patient experience throughout the cancer journey. To find more information, visit Carevive.com or contact john.elliott@carevive.com.

Recent Episodes

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

In “Fighting for Coverage,” a patient describes a double war: the physical fight to stay alive and the bureaucratic fight to prove to an insurer that her life is worth the cost. Her account spotlights a core tension in the U.S. system—coverage decisions are increasingly shaped by prior authorizations and desk-based reviewers who…

The sustainability of the healthcare system won’t be secured by another round of cost-cutting or clever benefit design alone, but by a hard cultural pivot toward alignment: payers, providers, employers, and patient advocates pulling on the same rope instead of grading each other on different exams. Right now we’ve built a maze that…